DAE HWA Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio
DAE HWA Pharmaceutical Co. Ltd working capital to net assets ratio. DAE HWA Pharmaceutical Co. Ltd (067080) has a Working Capital to Net Assets ratio of -62.5% as of June 2026. Working capital of ₩-53.61 Billion (current assets of ₩67.42 Billion minus current liabilities of ₩121.02 Billion) is measured against net assets of ₩85.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of DAE HWA Pharmaceutical Co. Ltd (2014–2025)
Working capital to net assets ratio of DAE HWA Pharmaceutical Co. Ltd from 2014 to 2025. This chart shows how DAE HWA Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at -62.5%, reflecting working capital of ₩-53.61 Billion against net assets of ₩85.72 Billion KRW. Explore DAE HWA Pharmaceutical Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
DAE HWA Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio by Year (2014–2025)
DAE HWA Pharmaceutical Co. Ltd working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for DAE HWA Pharmaceutical Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see DAE HWA Pharmaceutical Co. Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -74.7% | ₩-59.13 Billion | ₩79.14 Billion | ₩62.36 Billion | ₩121.48 Billion | ▲ +3.2 pp |
| 2024 | -77.9% | ₩-56.09 Billion | ₩72.00 Billion | ₩61.61 Billion | ₩117.69 Billion | ▲ +7.8 pp |
| 2023 | -85.7% | ₩-62.73 Billion | ₩73.23 Billion | ₩65.22 Billion | ₩127.95 Billion | ▼ -44.6 pp |
| 2022 | -41.1% | ₩-32.05 Billion | ₩77.99 Billion | ₩51.21 Billion | ₩83.26 Billion | ▼ -17.0 pp |
| 2021 | -24.1% | ₩-19.20 Billion | ₩79.67 Billion | ₩56.14 Billion | ₩75.34 Billion | ▲ +8.5 pp |
| 2020 | -32.5% | ₩-26.68 Billion | ₩81.98 Billion | ₩50.93 Billion | ₩77.61 Billion | ▼ -6.2 pp |
| 2019 | -26.3% | ₩-20.90 Billion | ₩79.35 Billion | ₩49.78 Billion | ₩70.68 Billion | ▼ -12.0 pp |
| 2018 | -14.4% | ₩-11.06 Billion | ₩76.88 Billion | ₩50.92 Billion | ₩61.98 Billion | ▲ +2.7 pp |
| 2017 | -17.1% | ₩-13.12 Billion | ₩76.75 Billion | ₩55.19 Billion | ₩68.32 Billion | ▼ -11.7 pp |
| 2016 | -5.4% | ₩-3.56 Billion | ₩66.15 Billion | ₩61.98 Billion | ₩65.54 Billion | ▼ -18.3 pp |
| 2015 | 12.9% | ₩7.90 Billion | ₩61.06 Billion | ₩55.89 Billion | ₩47.99 Billion | ▼ -1.8 pp |
| 2014 | 14.8% | ₩8.63 Billion | ₩58.51 Billion | ₩57.79 Billion | ₩49.16 Billion | — |